WST

West Pharmaceutical Services
D

WST

Arincen83/100B

West Pharmaceutical Services P/E ratio

West Pharmaceutical Services's P/E ratio is 45.94: its share price of 412.06 over its earnings per share of 8.97 over the last twelve months.

Today
45.94
Forward P/E, next 12 months
40.21
PEG ratio
2.82
Median, 5 years
42.30
Low, 5 years
24.73
High, 5 years
59.19

P/E ratio = price ÷ EPS (last 12 months) = 412.06 ÷ 8.97 = 45.94

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is West Pharmaceutical Services's P/E high compared with its own history?

West Pharmaceutical Services's P/E of 45.9 is above the middle of its 5-year range (24.7 to 59.2, median 42.3). Analysts expect faster growth than in recent years, which can explain part of the high P/E.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal yearPeriod endingP/E ratioForward P/EMarket capNet income
FY2027 · Estimate31 Dec 202739.77———
FY2026 · Estimate31 Dec 202643.42———
Today45.9440.2128.70B638.90M
FY202531 Dec 202540.2929.0119.89B493.70M
FY202431 Dec 202448.5346.1923.91B492.70M
FY202331 Dec 202344.0953.0926.16B593.40M
FY202231 Dec 202229.8929.3517.51B585.90M
FY202131 Dec 202152.7357.3834.89B661.80M
FY202031 Dec 202060.4831.2020.94B346.20M
FY201931 Dec 201946.0331.2011.12B241.70M
FY201831 Dec 201835.0131.207.24B206.90M
FY201731 Dec 201748.3935.197.29B150.70M
FY201631 Dec 201643.3030.626.22B143.60M
FY201531 Dec 201545.3527.314.34B95.60M
FY201431 Dec 201429.7029.053.77B127.10M
FY201331 Dec 201330.4128.033.41B112.30M
FY201231 Dec 201223.0718.011.86B80.70M
FY201131 Dec 201116.9418.781.28B75.50M
FY201031 Dec 201021.0117.171.37B65.30M
FY200931 Dec 200917.7120.211.29B72.60M
FY200831 Dec 200814.2318.701.22B86.00M
FY200731 Dec 200718.7818.131.33B70.70M
FY200631 Dec 200624.5924.201.65B67.10M
FY200531 Dec 200517.0815.46778.74M45.60M
FY200431 Dec 200438.7217.39751.20M19.40M
FY200331 Dec 200315.4019.70491.26M31.90M
FY200231 Dec 200219.1616.94352.58M18.40M
FY200131 Dec 200119.4617.50381.34M19.60M
FY200031 Dec 2000221.1516.14353.84M1.60M
FY199931 Dec 199911.9217.57461.14M38.70M
FY199831 Dec 199887.5214.39586.40M6.70M
FY199731 Dec 199711.0411.39490.30M44.40M
FY199631 Dec 199628.2711.39463.64M16.40M
FY199531 Dec 199513.5713.99389.42M28.70M
FY199431 Dec 199416.1814.96441.81M27.30M
FY199331 Dec 199317.30—389.34M22.50M
FY199231 Dec 199217.87—352.10M19.70M
FY199131 Dec 1991——288.07M-8.50M
FY199031 Dec 199045.33—194.93M4.30M
FY198931 Dec 198914.84—307.27M20.70M
FY198831 Dec 198814.02—243.93M17.40M
FY198731 Dec 198719.72—270.13M13.70M
FY198631 Dec 198613.32—226.45M17.00M
FY198531 Dec 198513.60—204.00M15.00M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

See also:Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about West Pharmaceutical Services's P/E ratio

Source: Financial Modeling Prep